RUNX2 and breast cancer: Runt-related transcription factor 2 (RUNX2) is a key driver of breast cancer bone metastasis; α5 integrin, as a critical RUNX2 target, augments the chemotactic and adhesive capabilities of breast cancer cells (Li et al., 2016).